Prediction of overall survival after neoadjuvant therapy

被引：0
|
作者：
Manekeller, Steffen
机构：
来源：
ZENTRALBLATT FUR CHIRURGIE | 2025年 / 150卷 / 01期
关键词：
D O I：
10.1055/a-2494-8626
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The aim was to predict poor overall survival in patients with pancreatic cancer treated with FOLFIRINOX based on clinical and computed tomography findings.
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [21] Tumor Regression Grade and Overall Survival Following Gastrectomy with Neoadjuvant Therapy for Gastric Cancer
    Sinnamon, Andrew J.
    Savoldy, Michelle A.
    Mehta, Rutika
    Pena, Luis
    Dineen, Sean P.
    Pimiento, Jose M.
    Lauwers, Gregory
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 404 - 404
  • [22] Prognostic markers for response and overall survival in patients with esophageal adenocarcinoma treated with neoadjuvant therapy
    Leers, J. M.
    Lurje, G.
    Yang, D.
    Oezcelik, A.
    Hagen, J. A.
    DeMeester, S. R.
    DeMeester, T. R.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Tumor regression grade and overall survival following gastrectomy with neoadjuvant therapy for gastric cancer
    Savoldy, Michelle A.
    Sinnamon, Andrew J.
    Mehta, Rutika
    Pena, Luis
    Dineen, Sean P.
    Lauwers, Gregory Y.
    Pimiento, Jose Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [24] Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
    Villano, Anthony M.
    O'Halloran, Eileen
    Goel, Neha
    Ruth, Karen
    Barrak, Dany
    Lefton, Max
    Reddy, Sanjay S.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 502 - 512
  • [25] Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma
    Silver, Casey M.
    Joung, Rachel H.
    Logan, Charles D.
    Benson, Al B.
    Mahalingam, Devalingam
    D'Angelica, Michael, I
    Bentrem, David J.
    Yang, Anthony D.
    Bilimoria, Karl Y.
    Merkow, Ryan P.
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 127 (01) : 90 - 98
  • [26] NATIONAL CANCER DATABASE VALIDATION OF NEOADJUVANT RECTAL (NAR) SCORE OVERALL SURVIVAL PREDICTION.
    Manguso, N.
    Naffouje, S.
    Powers, B.
    Sanchez, J.
    Dessureault, S.
    Felder, S.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [27] Factors predicting survival after neoadjuvant therapy with aromatase inhibitors
    Murray, E.
    Renshaw, L.
    Macaskill, E. J.
    Murray, J.
    McCaig, F.
    Young, O.
    Cameron, D.
    Kerr, G.
    Thomas, J. S.
    Dixon, J. M.
    BREAST, 2007, 16 : S50 - S51
  • [28] Factors predicting survival after neoadjuvant therapy with aromatase inhibitors
    Murray, E.
    Renshaw, L.
    Macaskill, E. J.
    Murray, J.
    McCaig, F.
    Young, O.
    Cameron, D.
    Kerr, G.
    Thomas, J.
    Jack, W.
    Dixon, J. M.
    EJC SUPPLEMENTS, 2007, 5 (03): : 3 - 3
  • [29] Impact on overall survival and disease-free survival of adjuvant chemotherapy after neoadjuvant chemoradiotherapy for rectal cancer
    de Castro, Rafael Amaral
    Paiva, Carlos Eduardo
    Saad-Hossne, Rogerio
    Michelin, Odair Carlito
    Souza, Cristiano de Padua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Time interval between neoadjuvant radiation therapy and surgery and overall survival of rectal cancer patients
    Amin, Saber A.
    Patel, Megha
    Lin, Chi
    COLORECTAL CANCER, 2024, 13 (01)
12345